References
1. CucinottaD, VanelliM: WHO declares COVID-19 a pandemic. Acta Biomed.
Mattioli 1885, 2020, pp. 157–160.
2. ZhouP, YangXLou, WangXG, et al.: A pneumonia outbreak associated with
a new coronavirus of probable bat origin. Nature Nature Research,
2020;579:270–273.
3. WuZ, McGooganJM: Characteristics of and Important Lessons from the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72314 Cases from the Chinese Center for Disease Control and
Prevention. JAMA - J. Am. Med. Assoc. American Medical Association,
2020, pp. 1239–1242.
4. WangD, HuB, HuC, et al.: Clinical Characteristics of 138 Hospitalized
Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA - J Am Med Assoc American Medical Association, 2020;323:1061–1069.
5. HuangC, WangY, LiX, et al.: Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet Lancet Publishing
Group, 2020;395:497–506.
6. GuoT, FanY, ChenM, WuX, ZhangL, HeT, WangH, WanJ, WangX, LuZ:
Cardiovascular Implications of Fatal Outcomes of Patients with
Coronavirus Disease 2019 (COVID-19). JAMA Cardiol American Medical
Association, 2020;.
7. Report sulle caratteristiche dei pazienti deceduti positivi a
COVID-19 in Italia Il presente report è basato sui dati aggiornati al 20
Marzo 2020.
8. Characteristics and Outcomes of Patients Hospitalized for COVID-19
and Cardiac Disease in Northern Italy - PubMed [Internet]. [cited
2020 May 20],. Available from:
https://pubmed.ncbi.nlm.nih.gov/32383763/?from_single_result=32383763&expanded_search_query=32383763
9. GreinJ, OhmagariN, ShinD, et al.: Compassionate Use of Remdesivir for
Patients with Severe Covid-19. N Engl J Med Massachusetts Medical
Society, 2020;.
10. FerrarioCM, JessupJ, ChappellMC, AverillDB, BrosnihanKB, TallantEA,
DizDI, GallagherPE: Effect of angiotensin-converting enzyme inhibition
and angiotensin II receptor blockers on cardiac angiotensin-converting
enzyme 2. Circulation 2005;111:2605–2610.
11. DonoghueM, HsiehF, BaronasE, GodboutK, GosselinM, StaglianoN,
DonovanM, WoolfB, RobisonK, JeyaseelanR, BreitbartRE, ActonS: A novel
angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts
angiotensin I to angiotensin 1-9. Circ Res 2000;87.
12. LetkoM, MarziA, MunsterV: Functional assessment of cell entry and
receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat
Microbiol Nature Research, 2020;5:562–569.
13. WallsAC, ParkYJ, TortoriciMA, WallA, McGuireAT, VeeslerD: Structure,
Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell
Cell Press, 2020;181:281-292.e6.
14. ZhengYY, MaYT, ZhangJY, XieX: COVID-19 and the cardiovascular
system. Nat. Rev. Cardiol. Nature Research, 2020, pp. 259–260.
15. OuditGY, KassiriZ, JiangC, LiuPP, PoutanenSM, PenningerJM, ButanyJ:
SARS-coronavirus modulation of myocardial ACE2 expression and
inflammation in patients with SARS. Eur J Clin Invest 2009;39:618–625.
16. ZhouT, WangZ, FanJ, ChenS, TanZ, YangH, YinY: Angiotensin-converting
enzyme-2 overexpression improves atrial remodeling and function in a
canine model of atrial fibrillation. J Am Heart Assoc 2015;4:e001530.
17. Activation of angiotensin-converting enzyme 2 improves cardiac
electrical changes in ventricular repolarization in
streptozotocin-induced hyperglyc… - PubMed - NCBI [Internet].
[cited 2020 May 19],. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/?term=24741027
18. LuYY, WuWS, LinYK, ChengCC, ChenYC, ChenSA, ChenYJ: Angiotensin 1-7
modulates electrophysiological characteristics and calcium homoeostasis
in pulmonary veins cardiomyocytes via MAS/PI3K/eNOS signalling pathway.
Eur J Clin Invest Blackwell Publishing Ltd, 2018;48.
19. ChenSA, ChangMS, ChiangBN, ChengKK, LinCI: Electromechanical effects
of angiotensin in human atrial tissues. J Mol Cell Cardiol
1991;23:483–493.
20. MehtaP, McAuleyDF, BrownM, SanchezE, TattersallRS, MansonJJ:
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. Lancet Publishing Group, 2020, pp. 1033–1034.
21. QinC, ZhouL, HuZ, ZhangS, YangS, TaoY, XieC, MaK, ShangK, WangW,
TianDS: Dysregulation of immune response in patients with COVID-19 in
Wuhan, China. Clin Infect Dis NLM (Medline), 2020;.
22. GuoY, LipGYH, ApostolakisS: Inflammation in atrial fibrillation. J.
Am. Coll. Cardiol. Elsevier USA, 2012, pp. 2263–2270.
23. HuYF, ChenYJ, LinYJ, ChenSA: Inflammation and the pathogenesis of
atrial fibrillation. Nat. Rev. Cardiol. Nature Publishing Group, 2015,
pp. 230–243.
24. LeeSH, ChenYC, ChenYJ, ChangSL, TaiCT, WongcharoenW, YehHI, LinCI,
ChenSA: Tumor necrosis factor-α alters calcium handling and increases
arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci
2007;80:1806–1815.
25. Aschar-SobbiR, IzaddoustdarF, KorogyiAS, et al.: Increased atrial
arrhythmia susceptibility induced by intense endurance exercise in mice
requires TNFα. Nat Commun Nature Publishing Group, 2015;6.
26. DuncanDJ, YangZ, HopkinsPM, SteeleDS, HarrisonSM: TNF-α and IL-1β
increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to
arrhythmia in rat ventricular myocytes. Cell Calcium Elsevier Ltd,
2010;47:378–386.
27. PrabhuSD: Cytokine-induced modulation of cardiac function. Circ.
Res. 2004, pp. 1140–1153.
28. LazzeriniPE, Laghi-PasiniF, AcampaM, et al.: Systemic Inflammation
Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of
Interleukin-6–Mediated Changes in Connexin Expression. J Am Heart Assoc
American Heart Association Inc., 2019;8.
29. BorthwickLA, WynnTA, FisherAJ: Cytokine mediated tissue fibrosis.
Biochim. Biophys. Acta - Mol. Basis Dis. 2013, pp. 1049–1060.
30. ChungCC, LinYK, ChenYC, KaoYH, LeeTI, ChenYJ: Vascular endothelial
growth factor enhances profibrotic activities through modulation of
calcium homeostasis in human atrial fibroblasts. Lab Investig Springer
Nature, 2020;100:285–296.
31. Castaño-RodriguezC, HonrubiaJM, Gutiérrez-ÁlvarezJ, et al.: Role of
severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a
in replication and pathogenesis. MBio American Society for Microbiology,
2018;9.
32. SuetomiT, WillefordA, BrandCS, ChoY, RossRS, MiyamotoS, BrownJH:
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to
Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ
Signaling in Cardiomyocytes Are Essential for Adverse Cardiac
Remodeling. Circulation Lippincott Williams and Wilkins,
2018;138:2530–2544.
33. YaoC, VelevaT, ScottL, et al.: Enhanced Cardiomyocyte NLRP3
Inflammasome Signaling Promotes Atrial Fibrillation. Circulation
Lippincott Williams and Wilkins, 2018;138:2227–2242.
34. TangTT, LvLL, PanMM, WenY, WangB, LiZL, WuM, WangFM, CrowleySD,
LiuBC: Hydroxychloroquine attenuates renal ischemia/reperfusion injury
by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell
Death Dis Nature Publishing Group, 2018;9.
35. SappJL, AlqarawiW, MacIntyreCJ, TadrosR, SteinbergC, RobertsJD,
LaksmanZ, HealeyJS, KrahnAD: Guidance On Minimizing Risk of Drug-Induced
Ventricular Arrhythmia During Treatment of COVID-19: A Statement from
the Canadian Heart Rhythm Society. Can J Cardiol Elsevier BV, 2020;.
36. JanuaryCT, WannLS, CalkinsH, et al.: 2019 AHA/ACC/HRS Focused Update
of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With
Atrial Fibrillation: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice
Guidelines and the Heart Rhythm Society in Collaboration With the
Society of Thoracic Surgeons. Circulation NLM (Medline),
2019;140:e125–e151.
37. CapelRA, HerringN, KallaM, YavariA, MiramsGR, DouglasG, BubG,
ChannonK, PatersonDJ, TerrarDA, BurtonRAB: Hydroxychloroquine reduces
heart rate by modulating the hyperpolarization-activated current If:
Novel electrophysiological insights and therapeutic potential. Hear
Rhythm Elsevier B.V., 2015;12:2186–2194.
38. BotelhoAFM, PierezanF, Soto-BlancoB, MeloMM: A review of cardiac
glycosides: Structure, toxicokinetics, clinical signs, diagnosis and
antineoplastic potential. Toxicon. Elsevier Ltd, 2019, pp. 63–68.
39. WesslerJD, GripLT, MendellJ, GiuglianoRP: The P-glycoprotein
transport system and cardiovascular drugs. J. Am. Coll. Cardiol. 2013,
pp. 2495–2502.
40. Drug interactions with antimalarial medications in older travelers:
a clinical guide. - PubMed - NCBI [Internet]. [cited 2020 May
19],. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/?term=31776555
41. Structural bases for the different anti-fibrillatory effects of
chloroquine and quinidine. - PubMed - NCBI [Internet]. [cited 2020
May 19],. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/?term=21233253
42. Rodríguez-MenchacaAA, Navarro-PolancoRA, Ferrer-VilladaT, RuppJ,
SachseFB, Tristani-FirouziM, Sánchez-ChapulaJA: The molecular basis of
chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad
Sci U S A National Academy of Sciences, 2008;105:1364–1368.
43. TaiCT, LinYK, LanFC, ChenHY, DingYA, ChangMS, ChenSA: Conduction
Properties of the Crista Terminalis in Patients with Atrial Flutter Due
to Amiodarone Therapy for Atrial Fibrillation. PACE - Pacing Clin
Electrophysiol 2003;26:2241–2246.
44. TaiCT, ChiangCE, LeeSH, ChenYJ, YuWC, FengAN, DingYA, ChangMS,
ChenSA: Persistent atrial flutter in patients treated for atrial
fibrillation with amiodarone and propafenone: Electrophysiologic
characteristics, radiofrequency catheter ablation, and risk prediction.
J Cardiovasc Electrophysiol Futura Publishing Company Inc.,
1999;10:1180–1187.
45. TaiCT, ChenSA, FengAN, YuWC, ChenYJ, ChangMS: Electropharmacologic
effects of class I and class III antiarrhythmia drugs on typical atrial
flutter: Insights into the mechanism of termination. Circulation
Lippincott Williams and Wilkins, 1998;97:1935–1945.
46. SpieziaL, BoscoloA, PolettoF, CerrutiL, TiberioI, CampelloE,
NavalesiP, SimioniP: COVID-19-Related Severe Hypercoagulability in
Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Thromb Haemost [Internet] Thromb Haemost, 2020 [cited 2020 May
20];. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32316063
47. VioliF, PastoriD, CangemiR, PignatelliP, LoffredoL: Hypercoagulation
and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.
Thromb Haemost [Internet] Georg Thieme Verlag KG, 2020 [cited 2020
May 20];. Available from:
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1710317
48. CuiS, ChenS, LiX, LiuS, WangF: Prevalence of venous thromboembolism
in patients with severe novel coronavirus pneumonia. J Thromb Haemost
Wiley, 2020;.
49. KlokFA, KruipMJHA, van derMeerNJM, ArbousMS, GommersDAMPJ, KantKM,
KapteinFHJ, vanPaassenJ, StalsMAM, HuismanMV., EndemanH: Incidence of
thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res Elsevier Ltd, 2020;.
50. AhmadI, RathoreFA: Neurological manifestations and complications of
COVID-19: A literature review. J Clin Neurosci [Internet] J Clin
Neurosci, 2020 [cited 2020 May 20];. Available from:
https://linkinghub.elsevier.com/retrieve/pii/S096758682031078X
51. COVID-19 and VTE-Anticoagulation - Hematology.org [Internet].
[cited 2020 May 20],. Available from:
https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
52. ChaoTF, ChiangCE, LinYJ, ChangSL, LoLW, HuYF, TuanTC, LiaoJN,
ChungFP, ChenTJ, LipGYH, ChenSA: Evolving changes of the use of oral
anticoagulants and outcomes in patients with newly diagnosed atrial
fibrillation in Taiwan. Circulation. Lippincott Williams and Wilkins,
2018, pp. 1485–1487.
53. The 2018 European Heart Rhythm Association Practical Guide on the
use of non-vitamin K antagonist oral anticoagulants in patients with
atrial fibri… - PubMed - NCBI [Internet]. [cited 2020 May
19],. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/?term=29562325
54. ReillyPA, LehrT, HaertterS, ConnollySJ, YusufS, EikelboomJW,
EzekowitzMD, NehmizG, WangS, WallentinL: The effect of dabigatran plasma
concentrations and patient characteristics on the frequency of ischemic
stroke and major bleeding in atrial fibrillation patients: The RE-LY
trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am
Coll Cardiol 2014;63:321–328.
55. Clinical outcomes, edoxaban concentration, and anti-factor Xa
activity of Asian patients with atrial fibrillation compared with
non-Asians in the E… - PubMed - NCBI [Internet]. [cited 2020 May
19],. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/?term=30590425
56. CalkinsH, HindricksG, CappatoR, et al.: 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation: Executive summary. J
Arrhythmia Elsevier B.V., 2017;33:369–409.
57. LakkireddyDR, ChungMK, GopinathannairR, et al.: Guidance for Cardiac
Electrophysiology During the Coronavirus (COVID-19) Pandemic from the
Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of
the American College of Cardiology; and the Electrocardiography and
Arrhythmias Committee of the Council on Clinical Cardiology, American
Heart Association. Hear Rhythm Elsevier BV, 2020;.
58. Atrial Fibrillation in Heart Failure: What Should We Do? - PubMed
[Internet]. [cited 2020 May 20],. Available from:
https://pubmed.ncbi.nlm.nih.gov/26419625/?from_single_result=26419625&expanded_search_query=26419625
59. BelhadjerZ, MéotM, BajolleF, et al.: Acute heart failure in
multisystem inflammatory syndrome in children (MIS-C) in the context of
global SARS-CoV-2 pandemic. Circulation [Internet] Circulation, 2020
[cited 2020 May 20];:CIRCULATIONAHA.120.048360. Available from:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.048360
60. PerkinsGD, MorleyPT, NolanJP, et al.: International Liaison
Committee on Resuscitation: COVID-19 Consensus on Science, Treatment
Recommendations and Task Force Insights. Resuscitation [Internet]
Resuscitation, 2020 [cited 2020 May 20];151. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/32371027
61. DrigginE, MadhavanMV., BikdeliB, et al.: Cardiovascular
Considerations for Patients, Health Care Workers, and Health Systems
During the COVID-19 Pandemic. J. Am. Coll. Cardiol. Elsevier USA, 2020,
pp. 2352–2371.
62. GreenlandJR, MichelowMD, WangL, LondonMJ: COVID-19 Infection:
Implications for Perioperative and Critical Care Physicians.
Anesthesiology NLM (Medline), 2020;.
63. Liverpool COVID-19 Interactions [Internet]. [cited 2020 May
20],. Available from: https://www.covid19-druginteractions.org/
Table 1. Interactions between medications for atrial
fibrillation and COVID-19.